top of page
Browse by category
Search


semaglutide could help dialysis patients qualify for kidney transplants
New research from Saint Louis University School of Medicine and SSM Health has revealed weight loss medications could help dialysis patients qualify for kidney transplants. The study is among the largest to examine semaglutide in dialysis patients. These individuals are often excluded from transplant waitlists because a high body mass index (BMI) increases surgical risks and impacts outcomes after transplantation. Key findings: Patients lost an average of 20.5 pounds after on
Browse by tag






bottom of page

